Results
1 -
10 of
209
(Click
here to explore results)
-
N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy. Lauren E. Scott, Maria Telpoukhovskaia, Cristina Rodríguez-Rodríguez, Michael Merkel, Meryn L. Bowen, Brent D. G. Page, David E. Green, Tim Storr, Fancy Thomas, David D. Allen, Paul R. Lockman, Brian O. Patrick, Michael J. Adam, Chris Orvig
, Chem. Sci.
, 2011
, 2
, 642
- Structural and thermodynamic stability of uranyl–deferiprone complexes and the removal efficacy of U(vi) at the cellular level. Xiaomei Wang, Guoxun Ji, Cen Shi, Juan Diwu, Lanhua Chen, Daxiang Gui, Jianmei Wan, Mark A. Silver, Jianqiang Wang, Shuao Wang
, Dalton Trans.
, 2018
, 47
, 8764
- Synthesis, physicochemical properties and antioxidant activity of deferiprone-cyclodextrin conjugates and their iron(iii) complexes. Antonino Puglisi, John Spencer, Valentina Oliveri, Graziella Vecchio, Xiaole Kong, James Clarke, John Milton
, Dalton Trans.
, 2012
, 41
, 2877
- Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one. J. I. Lachowicz, V. M. Nurchi, G. Crisponi, M. G. Jaraquemada-Pelaez, M. Arca, A. Pintus, M. A. Santos, C. Quintanova, L. Gano, Z. Szewczuk, M. A. Zoroddu, M. Peana, A. Domínguez-Martín, D. Choquesillo-Lazarte
, Dalton Trans.
, 2016
, 45
, 6517
- In vitro studies of lanthanide complexes for the treatment of osteoporosis. Yasmin Mawani, Jacqueline F. Cawthray, Stanley Chang, Kristina Sachs-Barrable, David M. Weekes, Kishor M. Wasan, Chris Orvig
, Dalton Trans.
, 2013
, 42
, 5999
- In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. David E. Green, Meryn L. Bowen, Lauren E. Scott, Tim Storr, Michael Merkel, Karin Böhmerle, Katherine H. Thompson, Brian O. Patrick, Harvey J. Schugar, Chris Orvig
, Dalton Trans.
, 2010
, 39
, 1604
- Solution chemistry of vanadium-(IV) and -(V) with the bidentate ligand 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone: relevance to the treatment of diabetes. Paul D. Taylor
, Chem. Commun.
, 1996
, 405
- Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application. Giuseppe Sciortino, Daniele Sanna, Valeria Ugone, Jean-Didier Maréchal, Eugenio Garribba
, Inorg. Chem. Front.
, 2019
, 6
, 1561
- Interaction between the low molecular mass components of blood serum and the VO(iv)–DHP system (DHP = 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone). Péter Buglyó, Tamás Kiss, Erzsébet Kiss, Daniele Sanna, Eugenio Garribba, Giovanni Micera
, J. Chem. Soc., Dalton Trans.
, 2002
, 2275
- Influence of temperature on the equilibria of oxidovanadium(iv) complexes in solution. Daniele Sanna, Giuseppe Lubinu, Valeria Ugone, Eugenio Garribba
, Dalton Trans.
, 2021
, 50
, 16326